Hartmut Ehrlich: CEO of Abivax

Portrait of Hartmut Ehrlich

Hartmut Ehrlich,  CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.

Historical image of Shionogi employee in the lab.
Shionogi

140 Years

Overseas Shipholding Group

Moving Energy with Integrity

Alexion Patient portrait
Alexion Pharmaceuticals

Patient Videos